Protexin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Protexin

What is Protexin? Identity and General Purpose

Property Description
Active Ingredient Sodium Ascorbate (Vitamin C)
Form Oral Syrup (Liquid Formulation)
Pharmacological Class Vitamin Supplement, Antioxidant
Common Use Prevention and treatment of Vitamin C deficiency
Origin Mineral Salt Derivative

Identity and Pharmacological Class

Protexin is classified as a vitamin supplement and an antioxidant, supplying the active component Sodium Ascorbate, which is a highly available form of Vitamin C (L-Ascorbate). It belongs to the water-soluble vitamin class, meaning the body requires consistent, regular intake, as it lacks substantial storage capacity for the compound. This necessity for steady external supply is widely recognized in nutritional guidelines.

The active ingredient is an organic sodium salt derived from Ascorbic Acid. Vitamin C acts as an essential cofactor in numerous enzyme systems and supports critical physiological processes.

Composition and Form: The Difference of Sodium Ascorbate

Protexin is typically delivered as an oral syrup, a liquid formulation administered orally. The preparation uniquely utilizes Sodium Ascorbate, which is a mineral salt derivative of the vitamin.

This specific compound is intentionally buffered and significantly less acidic than standard, pure Ascorbic Acid found in many other supplements. This characteristic is a key differentiating factor: it enhances patient tolerance, making the medicine easier to consume consistently, particularly for sensitive digestive systems or for patient groups requiring a readily accepted liquid format.

General Purpose and Core Physiological Role

The general purpose of Protexin is to support the body's overall structural and defense mechanisms by ensuring a continuous supply of the L-Ascorbate component. This role is essential for the proper development and repair of all bodily tissues and is intended to prevent or correct established states of Vitamin C deficiency.

The vitamin is clinically recognized for its critical involvement in the synthesis of collagen—a primary structural protein—and its function in enhancing the absorption of non-heme iron from the digestive tract, which supports physical maintenance. A typical use scenario involves supplementing individuals whose dietary intake is insufficient or those with increased metabolic demands.

What side effects are possible with Protexin?

Possible side effects and safety information

The safety profile of Ascorbic Acid, the active component in Protexin, is defined by officially documented side effects that primarily affect specific body systems and conditions related to prolonged, high-dose exposure.

Documented Adverse Reactions and Organ Systems

Adverse reactions are frequently reported without formal frequency classification in regulatory documents. The most commonly reported effects generally relate to:

  • Gastrointestinal Disorders: These include symptoms such as nausea, vomiting, diarrhea, heartburn, and abdominal cramps.
  • Nervous System Disorders: Reactions documented in this system include headache and disturbances in sleep, such as insomnia.
  • General Disorders: Fatigue and flushing are also noted as general adverse effects.

Serious Adverse Reactions and Duration Patterns

The most serious documented safety concerns are explicitly linked to the prolonged use of high doses of the compound. The regulatory documents emphasize that this exposure pattern may lead to serious renal events:

  • Oxalate Nephropathy and Nephrolithiasis: The formation of kidney stones or acute kidney injury due to the deposition of oxalate crystals is a documented risk associated with high-dose, long-term administration.

Population-Specific Safety Considerations

Regulatory labeling identifies several patient groups at increased risk for these serious effects:

  • Patients with Renal Compromise: Individuals with pre-existing renal impairment or a history of oxalate kidney stones are noted to have a higher risk for nephropathy.
  • G6PD Deficiency: Patients with Glucose-6-Phosphate Dehydrogenase deficiency are identified as being at increased risk for severe hemolysis.
  • Age Considerations: Specific safety notes exist for older adults and pediatric patients under two years of age.

Furthermore, because Protexin is formulated as Sodium Ascorbate, its sodium content must be a consideration for patients on sodium-restricted diets. The compound is also officially documented to interfere with certain laboratory tests based on oxidation-reduction reactions, such as blood and urine glucose assays.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

Overdose with Protexin (Sodium Ascorbate/Vitamin C) is primarily associated with the ingestion of massive or chronic excessive amounts, which can overwhelm the body’s metabolic capacity. Regulator-documented presentations generally fall into two categories:

Overdose Presentations Regulator-Documented Risks
Gastrointestinal Effects Nephrotoxicity and Hemolysis
Nausea, Vomiting, Diarrhea, Abdominal discomfort, Flatulence, Headache. Urolithiasis (kidney stone formation), Acute renal failure (due to oxalate deposition), Severe hemolytic anemia (in G6PDD patients).

Official labeling states that common symptoms like diarrhea and abdominal distress are generally transient. However, high-dose administration increases the risk of serious complications due to elevated oxalate levels. This includes oxalate kidney stone formation and subsequent acute renal failure; this risk is heightened in patients with pre-existing renal impairment, in geriatric patients, and in certain pediatric patients.

The most severe, population-specific risk documented is the potential for severe hemolytic anemia in individuals with Glucose-6-Phosphate Dehydrogenase Deficiency (G6PDD).

Seek immediate medical attention for any suspected overdose or if persistent or severe adverse symptoms, such as severe pain (suggesting stone formation) or signs of hemolysis, are experienced. No specific antidote is known; therefore, treatment is limited to supportive and symptomatic care, including monitoring of renal function and fluid status, as required by regulatory guidance.

Therapeutic Uses of Protexin

Quick Facts: Protexin Uses

  • Management of conditions associated with low Vitamin C levels.
  • Supports the maintenance of healthy skin, cartilage, and bone structure.
  • Contributes to the management of scurvy and its associated symptoms.
  • Aids the body's protective mechanisms against cell damage.

Protexin (Ascorbic Acid) is indicated for the prevention and management of conditions resulting from a deficiency of Vitamin C in the diet, such as scurvy. The medication works to support the body's natural maintenance of various tissues, including skin, cartilage, teeth, and blood vessels. It contributes to multiple essential biological functions, including assisting the body in using carbohydrates, fats, and protein.

In clinical practice, Protexin may be used to support the healing of wounds. It may also be prescribed to address increased Vitamin C requirements associated with certain underlying conditions or life stages. Individuals should consult their healthcare provider to determine the appropriate use and potential benefit in their specific context.

Eligibility and Restrictions for Use

Protexin (Sodium Ascorbate) eligibility is strictly defined by regulatory documents, outlining populations for whom use is prohibited, restricted, or conditional.

Contraindicated Populations

The medicine is strictly contraindicated for individuals with known hypersensitivity to the active ingredient or any excipients. Use is also prohibited in patients with severe renal insufficiency or renal failure and those with certain iron or blood disorders, specifically hemochromatosis and G6PD deficiency (at higher doses). Individuals with a history of recurrent kidney stones must not use the medicine due to the risk of oxalate precipitation.

Age and Life Stage Constraints

Infants younger than five months of age are generally not recommended to use the medicine. Caution is required for pediatric patients under two years old and for older adults, where age-related decrease in renal function warrants special consideration. For pregnant or breastfeeding women, the medicine is considered conditionally safe, but its administration is restricted to situations where it is clearly needed to treat deficiency. Furthermore, patients on salt-restricted diets should use caution, as the Sodium Ascorbate component contains sodium.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Protexin (Sodium Ascorbate) is defined by its chemical properties and effects on co-administered substances, as documented in official regulatory sources. No combinations are formally classified as contraindicated combinations.

Pharmacodynamic and Exposure Interactions

Ascorbic acid may cause acidification of the urine at high doses, a pharmacodynamic effect that alters the renal excretion of drugs sensitive to pH changes. This can decrease the serum levels of weak base drugs, such as Amphetamine and Tricyclic Antidepressants.

Exposure modification is documented with specific medicines:

  • Oral Contraceptives: Ascorbic acid has been reported to increase the bioavailability of Ethinyloestradiol.
  • Warfarin: Some regulatory data suggests ascorbic acid may reduce the effect of Warfarin, necessitating continued standard monitoring.
  • Oral Iron: Ascorbic acid increases the gastrointestinal absorption of non-heme iron.

Timing and Substance Restrictions

Specific restrictions apply when Protexin is used with certain agents. Co-administration with aluminum-containing antacids may increase the absorption of aluminum. Furthermore, alcohol is documented to reduce ascorbic acid levels in the body.

When co-administered with the iron chelator Desferrioxamine, specific timing rules apply. The ascorbic acid dose should be administered after the chelator treatment has been established, and ideally soon after the chelator infusion begins.

Interference with Laboratory Tests

Protexin may interfere with laboratory tests based on oxidation-reduction reactions, including certain tests for blood and urine glucose. To prevent inaccurate results, official guidance states that testing should be delayed for at least 24 hours following administration.

Mechanism of Action

How Protexin Works

L-Ascorbate (the active molecule) functions primarily as a necessary substrate reductant for several iron-dependent hydroxylase enzymes. In this capacity, it maintains the iron in its active Fe^2+ state, which is essential for enzymes like Prolyl Hydroxylase and Lysyl Hydroxylase to perform their catalytic function. This molecular action enables the crucial cross-linking required for the proper formation of the collagen triple helix, directly supporting the stability of structural proteins within blood vessels, bone, and connective tissues.

Concurrently, L-Ascorbate acts as an effective, water-soluble electron donor that neutralizes damaging Reactive Oxygen Species (ROS) throughout the body. This scavenging process modulates redox homeostasis and reduces oxidative damage to cellular components, including DNA and lipids. Furthermore, the molecule chemically mediates iron availability by reducing poorly absorbed ferric iron ( Fe^3+) in the gut lumen to the readily absorbed ferrous form ( Fe^2+). This mechanism, however, is physiologically constrained by saturable intestinal transporters ( SVCT), which limits systemic uptake.

Dosage and Administration Information

Administration and Official Dosing Rules

Protexin is administered based on parameters that establish its administration route, dosage, and frequency patterns for treating Vitamin C deficiency. The product, an oral liquid formulation of Sodium Ascorbate, is designated for the oral route, which is the primary method of administration.

Administration Protocol

The oral liquid may be taken directly by mouth or is commonly mixed with food or beverages like fruit juice or cereal to facilitate intake. The intravenous (IV) route is an approved alternative, but it is strictly reserved for patients with severe deficiency or those unable to tolerate oral administration.

Standard adult oral dosing for the treatment of deficiency generally falls within the range of 100 mg to 250 mg, typically administered once or twice daily. When the IV route is required for severe deficiency, the dose is 200 mg administered once per day.

Duration and Special Conditions

The duration of use is time-bound: oral treatment requires a minimum course of two weeks, while IV administration is restricted to a maximum of seven days, after which a transition to the oral route is indicated. Dosing must adhere to specific population rules, such as ensuring that consumption during pregnancy or lactation does not exceed established Recommended Dietary Allowance (RDA) levels. For the IV route, the solution must be mandatorily diluted to an isotonic state prior to administration via slow intravenous infusion and must be shielded from light exposure.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Protexin (Sodium Ascorbate)


Evidence for Managing Vitamin C Deficiency (Scurvy)

The use of Vitamin C, the active component of Protexin, for deficiency states, known as scurvy, was studied for many decades. This evidence base consists primarily of historical controlled trials, observational studies, and clinical case series. Researchers monitored the resolution of clinical symptoms, such as gum inflammation and fatigue, and measured the movement toward normalization of plasma or leukocyte Vitamin C levels. These studies report patterns where the clinical signs of scurvy evolved toward resolution following the introduction of the component.

However, modern, large-scale Randomized Controlled Trials (RCTs) focusing specifically on treating overt, severe scurvy are not available. Research describing the specific intake levels for individuals with subclinical deficiency versus overt scurvy is not precisely defined by uniform, contemporary trial data.


Evidence for Support in Wound Healing and Tissue Maintenance

The role of Vitamin C in the body’s repair processes was evaluated in various settings, including RCTs and systematic reviews that examined whether administration was associated with changes in measured outcomes in contexts requiring tissue repair, such as patients with chronic wounds or those recovering from surgery. Outcomes measured included the rate of wound closure and strength of scar tissue.

Some trials reported changes measured during the study period, particularly in study groups that had low baseline Vitamin C levels. However, the evidence is limited, and findings were mixed when studies involved populations who were not deficient at the start. The frequent co-administration of Vitamin C with other nutrients is a factor that makes the specific influence of the Vitamin C component alone remains uncertain.


Long-Term Studies and Follow-up Data

Research on Protexin's active component has largely focused on short-term symptom changes, where follow-up durations were limited (often days to a few weeks). There is limited information for long-term outcomes regarding the durability of effects observed in studies of tissue support or the extended follow-up of vascular markers. Existing studies provide context but not individual predictions about the need for continued, long-term administration to maintain specific physiological functions in non-deficient individuals.

Key Studies & References

  1. Systematic review and meta-analysis of Vitamin C supplementation on endothelial function
  2. Assessment of Scurvy and Hypovitaminosis C in Clinical Practice: Historical Context and Modern Management

Frequently Asked Questions (FAQ)

Common questions about Protexin (FAQ)

Q: Can children take Protexin, and is there a specific dose for them?

A: Official health guidance indicates that the medicine is generally suitable for use in children. However, caution is advised for infants under five months and for pediatric patients younger than two years old. Administration should align with established U.S. Recommended Dietary Allowance (RDA) levels for the relevant age group, as these are conditional requirements.


Q: How does Protexin work inside the digestive system?

A: The active component is absorbed from the digestive tract, primarily in the small intestine, through specialized protein channels called sodium-dependent vitamin C transporters. The number of these channels is one factor that limits the total amount of the component that the body can absorb.


Q: Does taking Protexin affect your immune system?

A: Official information indicates that the active component acts as a strong antioxidant, which plays a role in numerous physiological processes. In this function, it is understood to play a role in supporting the body’s general defense mechanisms and contributing to the maintenance of the body's protective barriers.


Q: What is the main ingredient that makes Protexin work?

A: The product's effectiveness comes from its active ingredient, Sodium Ascorbate (a form of Vitamin C). The component is officially recognized for its involvement in critical functions, such as acting as a cofactor for enzymes required to form and maintain body tissues like collagen.


Q: Can Protexin cause constipation or diarrhea?

A: Regulatory documents list gastrointestinal side effects such as diarrhea, nausea, vomiting, and abdominal cramps, especially when high doses are administered. Constipation, however, is not generally listed among the commonly documented adverse reactions in the product's official information.


Q: Can a diabetic patient safely use Protexin?

A: Official regulatory warnings note that the active component can potentially interfere with certain laboratory tests that rely on oxidation-reduction reactions. This interference is a relevant consideration because it involves certain assays used to measure blood and urine glucose levels.


Q: Why do doctors sometimes recommend Protexin?

A: The product is officially indicated for the prevention and treatment of Vitamin C deficiency (scurvy). It is also recognized for its role in supporting the body's natural synthesis of collagen for tissue maintenance and enhancing the intestinal absorption of iron.


Q: Is it normal to feel a little bloated when first starting Protexin?

A: Gastrointestinal side effects such as abdominal cramps and gas are documented in the official adverse reaction data. However, bloating is not generally listed as a standard adverse reaction in regulatory documents for this compound.


Q: What happens if I stop taking Protexin suddenly?

A: Regulatory information indicates that prolonged use of very large doses of the active component may induce a state of tolerance in the body. If intake is rapidly reduced from these high levels to normal amounts, this sudden change could potentially result in a return of symptoms related to deficiency.


Q: How long can someone safely take Protexin continuously?

A: Regulatory documents emphasize that the prolonged use of high doses is associated with a documented risk of serious renal events. This includes the potential formation of kidney stones (nephrolithiasis) or acute kidney injury.


Q: Does Protexin interact with common over-the-counter pain relievers?

A: Official drug interaction information suggests caution when combining the active component with certain nonsteroidal anti-inflammatory drugs (NSAIDs), which are common OTC pain relievers. This combination may be associated with an increased risk of specific kidney issues.


Q: Is there a best time of day to take Protexin?

A: According to the official administration protocol, there is no specific time of day that is mandated for consumption. The product is generally taken once or twice daily and can be taken with or without food.


Q: Is it possible to be allergic to Protexin?

A: Official regulatory documents indicate that the medicine is strictly contraindicated for individuals with a known hypersensitivity (allergic reaction) to the active ingredient, Sodium Ascorbate, or to any other components in the formulation.


Q: Can Protexin be mixed with food or drink?

A: Yes, the official administration protocol confirms that the oral liquid can be mixed with food or beverages. Common choices include fruit juice or cereal, which is done to help facilitate intake.


Q: Are there any specific lifestyle changes that improve Protexin's efficacy?

A: Official health guidance suggests that cigarette smoking may decrease the effectiveness of the active component in the body. Therefore, avoiding smoking is considered a lifestyle factor that may help maintain the medicine's efficacy.


Q: Does Protexin interact with birth control pills?

A: Regulatory information states that the active component has been reported to increase the bioavailability (absorption into the bloodstream) of Ethinyloestradiol. Ethinyloestradiol is a common component found in many types of oral contraceptive pills.


Q: Does Protexin need to be taken with food?

A: No, it is not strictly required to be taken with food. The administration protocol indicates it may be taken directly by mouth or that it can be mixed with food or beverages if preferred.


Q: Can Protexin cause acid reflux or heartburn?

A: Heartburn is explicitly listed as a potential adverse reaction in regulatory documents, along with other gastrointestinal disturbances. Acid reflux is a related GI issue that may occur.


Q: If I miss a dose of Protexin, what should I do?

A: Official guidance describes a protocol for missed doses: if a dose is forgotten, it is typically advised to take it as soon as remembered. However, if it is almost time for the next scheduled dose, the instruction is generally to skip the missed one and continue the regular regimen, avoiding a double dose.

How should Protexin be stored and disposed of?

The storage and disposal of Protexin Oral Syrup (Sodium Ascorbate) must adhere strictly to official regulatory guidelines to ensure stability and safety.

Storage & Disposal Scope

Scope Element Official Regulatory Requirement
Labeled storage temperature Store at controlled room temperature, typically 20 C to 25 C
Light/moisture protection Protect from light and keep the container tightly closed
Handling requirements Do not freeze; refrigeration is not required
Packaging-related storage Store in original container
Child-protection storage Keep out of the sight and reach of children
Disposal instructions Dispose of unused product according to local regulations

Resulting Storage & Disposal Structure

Official regulatory documents mandate that the syrup be stored within a specific controlled room temperature range and protected from freezing to maintain product stability. The container must be kept tightly closed and in its original packaging. Disposal is regulated, requiring that unused product be handled responsibly, avoiding release into drains or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Protexin found in:

A-Z Index: